Funding Details
- Awarder
- Inbox
- Date Award
- March 31, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$73,900,000
Company Info
- Company Description
- Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
- Market
- Gene Editing
- Location
-
Cambridge,
MA,
USA
- Coinvestors
- Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Deep Track Capital, Kerna Ventures, Partners Investment Co., Piper Heartland Healthcare Capital, QIA, Revelation Partners, Surveyor Capital, T. Rowe Price Associates, TCGX, Temasek, Vertex Pharmaceuticals
Links